1. 1061PMolecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial. (23rd October 2018) Authors: Houessinon, A; Verlingue, L; Hollebecque, A; Even, C; Lacroix, L; Postel-Vinay, S; Varga, A; El Dakdouki, Y; Balheda, R; Michot, J-M; Gazzah, A; Marabelle, A; Michiels, S; Rouleau, E; Breuskin, I; de Baere, T; Angevin, E; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 109TiPAcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types. (17th December 2018) Authors: Marabelle, A; Chevret, S; Janot, F; Escudier, B; Pouessel, D; Tournigand, C; Hoang-Xuan, K; Mortier, L; Rousseau, B J-C; Schlumberger, M J; Ray-Coquard, I L; Blay, J-Y; Niccoli, P; Jaccard, A; Couch, D; Hoog-Labouret, N; Pauporte, I; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 110TiPA phase I dose escalation trial evaluating the impact of an in situ immunization strategy with intra-tumoral injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions. (17th December 2018) Authors: Marabelle, A; Eberst, L; Terret, C; Pilleul, F; Mastier, C; Bouhamama, A; Gilles-Afchain, L; Laurent, S; Delzano, I; Reynaud, C; Caux, C; Caux, C; Garin, G; Bidaux, A-S; Perol, D; Stojkowitz, N; Homerin, M; Leenders, H; Cassier, P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 10 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1141PDAssociation between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1. (23rd October 2018) Authors: Kfoury, M; Voisin, A-L; Najean, M; Champiat, S; Laghouati, S; Michot, J-M; Robert, C; Mateus, C; Albiges, L; Besse, B; Massard, C; Texier, M; Lambotte, O; Marabelle, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1206PIncidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. (23rd October 2018) Authors: Baldini, C; Martin-Romano, P; Voisin, A-L; Danlos, F X; Champiat, S; Laghouati, S; Kfouri, M; Vincent, H; Nagera, C; Postel-Vinay, S; Varga, A; Ribrag, V; Besse, B; Hollebecque, A; Lambotte, O; Michot, J-M; Soria, J-C; Massard, C; Marabelle, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 162TiP A phase I study evaluating BI 765063, a first in class selective myeloid SIRPa inhibitor, as standalone and in combination with BI 754091, a programmed death-1 (PD-1) inhibitor, in patients with advanced solid tumours. (15th December 2019) Authors: Marabelle, A; Cassier, P; Delord, J-P; Jungles, C; Champiat, S; Vinceneux, A; Korakis, I; Huhn, R; Poirier, N; Vasseur, B; Kotecki, N Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1843PMolecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. (23rd October 2018) Authors: Vuagnat, P; Baldini, C; Verlingue, L; Martin Romano, P; Varga, A; Hollebecque, A; Postel-Vinay, S; Gazzah, A; Bahleda, R; Marabelle, A; Ribrag, V; Champiat, S; Michot, J-M; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1885PPrecision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial. (23rd October 2018) Authors: Abdelshafy, M; El Dakdouki, Y; Verlingue, L; Hollebecque, A; Lacroix, L; Postel-Vinay, S; Varga, A; Balheda, R; Michot, J-M; Marabelle, A; Rouleau, E; Solary, E; de Baere, T; Angevin, E; Ribrag, V; Michiels, S; André, F; Scoazec, J-Y; Soria, J-C; Massard, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3OApplicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials. (27th February 2019) Authors: Varga, A; Bernard-Tessier, A; Auclin, E; Mezquita Pérez, L; Baldini, C; Planchard, D; Marabelle, A; Hollebecque, A; Besse, B; Massard, C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 49P Thromboembolic risk assessment in patients receiving combination of anti-angiogenic plus anti-PD1 or anti-PD-L1: A descriptive study. (15th December 2019) Authors: Bravo, P; Vss, B; Baldini, C; Romano, P Martin; Hollebecque, A; Varga, A; Vuagnat, P; Champiat, S; Marabelle, A; Escudier, B; Albiges, L; Loriot, Y; Massard, C; Cataldi, A; Babai, S; Voisin, A-L; Lambotte, O; Annereau, M; Michot, J-M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗